Carnegie Investment Counsel Reduces Stock Position in Marsh & McLennan Companies, Inc. $MMC

Carnegie Investment Counsel trimmed its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMCFree Report) by 6.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,020 shares of the financial services provider’s stock after selling 6,375 shares during the period. Carnegie Investment Counsel’s holdings in Marsh & McLennan Companies were worth $19,552,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Brighton Jones LLC lifted its holdings in shares of Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after buying an additional 2,960 shares in the last quarter. Bison Wealth LLC boosted its holdings in Marsh & McLennan Companies by 39.6% in the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock valued at $651,000 after purchasing an additional 869 shares during the period. Trexquant Investment LP bought a new position in shares of Marsh & McLennan Companies in the first quarter worth $4,254,000. State of Wyoming bought a new stake in Marsh & McLennan Companies during the first quarter valued at $72,000. Finally, WPG Advisers LLC purchased a new position in Marsh & McLennan Companies during the first quarter worth about $181,000. 87.99% of the stock is owned by institutional investors.

Marsh & McLennan Companies Stock Down 0.3%

Shares of NYSE MMC opened at $187.10 on Friday. The company has a market cap of $91.66 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 3.22 and a beta of 0.75. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 1.19. The firm’s fifty day moving average is $183.04 and its 200 day moving average is $198.62. Marsh & McLennan Companies, Inc. has a 52 week low of $174.18 and a 52 week high of $248.00.

Marsh & McLennan Companies (NYSE:MMCGet Free Report) last issued its quarterly earnings data on Thursday, October 16th. The financial services provider reported $1.85 EPS for the quarter, beating the consensus estimate of $1.78 by $0.07. The firm had revenue of $6.35 billion during the quarter, compared to the consensus estimate of $6.34 billion. Marsh & McLennan Companies had a net margin of 15.60% and a return on equity of 31.79%. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.63 earnings per share. On average, equities research analysts expect that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO John Q. Doyle sold 21,079 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $182.22, for a total transaction of $3,841,015.38. Following the transaction, the chief executive officer directly owned 87,681 shares of the company’s stock, valued at approximately $15,977,231.82. The trade was a 19.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Wolfe Research initiated coverage on Marsh & McLennan Companies in a research report on Tuesday, September 16th. They set a “peer perform” rating for the company. The Goldman Sachs Group raised shares of Marsh & McLennan Companies from a “sell” rating to a “neutral” rating and cut their price target for the stock from $200.00 to $195.00 in a research note on Monday, October 20th. Wells Fargo & Company cut their target price on shares of Marsh & McLennan Companies from $222.00 to $212.00 and set an “equal weight” rating for the company in a research report on Friday, October 17th. Keefe, Bruyette & Woods raised Marsh & McLennan Companies from an “underperform” rating to a “market perform” rating and dropped their price target for the stock from $209.00 to $191.00 in a research note on Friday, October 17th. Finally, JPMorgan Chase & Co. upgraded Marsh & McLennan Companies from a “neutral” rating to an “overweight” rating and reduced their price objective for the company from $248.00 to $242.00 in a research report on Thursday, October 9th. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $222.35.

Get Our Latest Stock Analysis on MMC

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Read More

Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMCFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MMC)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.